
Vipride PM 2mg/500mg/15mg Tablet
Marketer
Aver Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Vipride PM 2mg/500mg/15mg Tablet
Glycemia-Control 2-500-15 Tablet is a triple-combination medication formulated to manage blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It promotes efficient insulin use, consequently reducing blood sugar. Glycemia-Control 2-500-15 Tablets should be administered as prescribed by your physician, adhering to the recommended dosage and duration. Ingestion with food is advised to mitigate gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume the regular schedule. Avoid doubling the dose. An overdose may result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Kidney function tests will be conducted prior to treatment initiation. Limit alcohol consumption, as this can heighten the likelihood of side effects.
Uses of Vipride PM 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Vipride PM 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Vipride PM 2mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
Common Side effects of Vipride PM 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Vipride PM 2mg/500mg/15mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the Vipride PM 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption should coincide with a meal.
How Vipride PM 2mg/500mg/15mg Tablet works:
Vipride PM 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vipride PM 2mg/500mg/15mg tablets with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Vipride PM 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Vipride PM 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available data from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Vipride PM 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. The use of Vipride PM 2mg/500mg/15mg tablets is contraindicated in patients exhibiting severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Vipride PM 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Vipride PM 2mg/500mg/15mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Vipride PM 2mg/500mg/15mg Tablet :
Should you forget a Vipride PM 2mg/500mg/15mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vipride PM 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
